BRITISH JOURNAL OF PHARMACOLOGY

The British Journal of Pharmacology (ISSN 0007-1188) is a distinguished international journal published by the British Pharmacological Society and distributed by Wiley-Blackwell, serving as a premier venue for high-impact research in the field of pharmacology. Published bi-monthly in the United Kingdom, the journal maintains a strong reputation for rigorous peer review and scientific excellence, reflected in its 2022 impact factor of 7.3 and its classification as a Category 1 medical journal by the Chinese Academy of Sciences (CAS). As an SCI-indexed publication, it welcomes interdisciplinary studies that bridge fundamental and clinical pharmacology, with a particular emphasis on drug mechanisms of action, receptor pharmacology, signal transduction, and drug discovery and development. Although the journal operates on a subscription-based model rather than open access, its stringent criteria for methodological rigor and novelty result in a highly competitive submission process and a relatively high rejection rate. Consequently, while the British Journal of Pharmacology offers significant prestige and visibility for authors, prospective contributors should be prepared for a demanding review cycle that may involve extended publication timelines due to the journal’s commitment to maintaining high-quality standards.